Primarily utilized in pharmaceutical research and development, this compound serves as a key intermediate in the synthesis of various biologically active molecules. Its unique structure, featuring a trifluoromethyl group and a tetrahydrotriazolopyrazine core, makes it valuable for designing drugs targeting central nervous system disorders, such as anxiety and depression. Additionally, it is explored for its potential in creating novel therapeutics for metabolic and cardiovascular diseases. The compound’s trifluoromethyl group enhances its metabolic stability and bioavailability, making it a promising candidate for drug discovery efforts. Researchers also investigate its role in developing enzyme inhibitors and receptor modulators due to its ability to interact with specific biological targets.